News
Company ImmuPharma PLC
TIDM IMM
Headline Result of AGM
Released 12:02 17-Jun-2010
Number 7971N12
FOR IMMEDIATE RELEASE
London, 17 June 2010
Result of Annual General Meeting
ImmuPharma PLC (AIM:IMM), the specialist drug discovery and development company, held its AGM earlier today and is pleased to announce that all resolutions were duly passed.
For further information please contact:
ImmuPharma PLC +44 20 7152 4080
Dimitri Dimitriou, Chief Executive Officer
Richard Warr, Chairman
Buchanan Communications +44
20 7466 5000
www.buchanan.uk.com
Lisa Baderoon
Catherine Breen
George Prassas
Panmure Gordon & Co 44 151 243 0963
Andrew Burnett
Rakesh Sharma
Execution Noble & Co +44 20 7456 9191
James Bromhead
© London Stock Exchange plc. All rights reserved